CEPRES, a provider of portfolio forecasting for Private Markets, is advising clients to use 10 per cent VaR (Value at Risk) forecasts for 2020 and 2021 due to the COVID-19 outbreak. 

As an asset class with a buy-to-sell cycle that typically lasts around five to seven years, you would be forgiven for thinking that private equity could weather the storm of Covid-19 more smoothly than other, more inherently volatile asset classes, can. That’s partly true.

Kenyan health tech startup Afya Rekod is about to launch an AI and blockchain consumer-driven, health data platform in support of global efforts to curb the coronavirus pandemic.

Covid-19 fallout continues to hit firms across the world, both in terms of supply and demand, and the predicted ensuing recession is likely to change how we live in the future. While the outbreak has unsettled lives and businesses across the world, delaying deal processes and fundraising, there are ‘new world’ sectors that will do well.

New data reveals that 33 per cent of UK businesses say they lack the technology infrastructure to manage long-term remote working during the Covid-19 crisis.

Over half of large and medium sized businesses (55 per cent) expect a substantial revenue drop this year due to the Coronavirus outbreak.